Shao YJ - Search Results

1

Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan.

Lee PH, Chen IC, Chen YM, Hsiao TH, Tseng JS, Huang YH, Hsu KH, Lin H, Yang TY, Shao YJ. Lee PH, et al. Among authors: shao yj. JCO Precis Oncol. 2024 Oct;8:e2400236. doi: 10.1200/PO.24.00236. Epub 2024 Oct 2. JCO Precis Oncol. 2024. PMID: 39348659

2

scdNet: a computational tool for single-cell differential network analysis.

Chiu YC, Hsiao TH, Wang LJ, Chen Y, Shao YJ. Chiu YC, et al. Among authors: shao yj. BMC Syst Biol. 2018 Dec 21;12(Suppl 8):124. doi: 10.1186/s12918-018-0652-0. BMC Syst Biol. 2018. PMID: 30577836 Free PMC article.

3

A Novel Quality-Control Procedure to Improve the Accuracy of Rare Variant Calling in SNP Arrays.

Sun TH, Shao YJ, Mao CL, Hung MN, Lo YY, Ko TM, Hsiao TH. Sun TH, et al. Among authors: shao yj. Front Genet. 2021 Oct 26;12:736390. doi: 10.3389/fgene.2021.736390. eCollection 2021. Front Genet. 2021. PMID: 34764980 Free PMC article. Review.

4

Multi-omics analysis reveals the BRCA1 mutation and mismatch repair gene signatures associated with survival, protein expression, and copy number alterations in prostate cancer.

Hsiao TH, Chiu YC, Shao YJ. Hsiao TH, et al. Among authors: shao yj. Transl Cancer Res. 2019 Aug;8(4):1279-1288. doi: 10.21037/tcr.2019.07.05. Transl Cancer Res. 2019. PMID: 35116870 Free PMC article.

5

Parental autoimmunity and offspring risks of rheumatic diseases: a nationwide population-based study.

Shao YJ, Chen YM. Shao YJ, et al. Rheumatology (Oxford). 2024 Aug 1;63(8):2189-2198. doi: 10.1093/rheumatology/kead562. Rheumatology (Oxford). 2024. PMID: 37878801

6

Clinical relevance of protein-truncating variants of germline DNA repair genes in prostate cancer.

Shao YJ, Liao CS, Hsu YC, Chiu YC, Lu TJ, Ou YC, Hsiao TH. Shao YJ, et al. BMC Cancer. 2024 Oct 25;24(1):1319. doi: 10.1186/s12885-024-13045-4. BMC Cancer. 2024. PMID: 39455978 Free PMC article.

7

Letter: cohort study examining the association between proton pump inhibitors therapy and risk of hepatocellular carcinoma in Taiwan-authors' reply.

Shao YJ, Wu SY. Shao YJ, et al. Aliment Pharmacol Ther. 2018 Sep;48(6):690-691. doi: 10.1111/apt.14935. Aliment Pharmacol Ther. 2018. PMID: 30132942 No abstract available.

8

Early-onset prostate cancer is associated with increased risks of disease progression and cancer-specific mortality.

Shih HJ, Fang SC, An L, Shao YJ. Shih HJ, et al. Among authors: shao yj. Prostate. 2021 Feb;81(2):118-126. doi: 10.1002/pros.24087. Epub 2020 Nov 5. Prostate. 2021. PMID: 33152137

9

Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia.

Huang CY, Fang SC, Shao YJ. Huang CY, et al. Among authors: shao yj. JAMA Netw Open. 2021 May 3;4(5):e218810. doi: 10.1001/jamanetworkopen.2021.8810. JAMA Netw Open. 2021. PMID: 33974056 Free PMC article.

10

Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan.

Shao YJ, Hong JH, Chen CK, Huang CY. Shao YJ, et al. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):722-729. doi: 10.1038/s41391-022-00555-0. Epub 2022 Jun 3. Prostate Cancer Prostatic Dis. 2023. PMID: 35662291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters